logo

Every week, the Editor-in-Chief selects an Article of the Week from the current issue of BJUI. The abstract is reproduced below and you can click on the button to read the full art[...]
What is the threat posed by your disease? This is how I begin all my conversations with men who have newly diagnosed prostate cancer. For men with obvious metastatic disease, the c[...]
BJUI – BJU International · The ProtecT trial: Part of the BURST/BJUI Podcast Series Mr Joseph Norris is a Specialty Registrar in Urology in the London Deanery. He is cur[...]
  ≠WeAreNotAfraid. Perhaps the standout memory of EAU – London 2017. The 32nd Annual EAU Congress in London was marked with a message of defiance from colleagues and delegates from[...]
The BJUI supports clinical trials. Plain, simple, and with some new strategies. Randomised clinical trials (RCTs) are the highest level of evidence-based medicine. We know this to [...]
Patient-reported outcomes in the ProtecT randomized trial of clinically localized prostate cancer treatments: study design, and baseline urinary, bowel and sexual function and qual[...]
We are having an amazing year of scientific discovery in our specialty. 2016 has already seen the results of the only randomised trial comparing open versus robotic radical prostat[...]
The widely anticipated results of the ProtecT study have now been published. Unfortunately, the results do little to advance our understanding as to whether surgery or radiation pr[...]